Call us now :08071793621
Send Inquiry
Send InquiryBosutris 400 mg Tablet
Bosutris 400 mg Tablet Specification
- Pacakaging (Quantity Per Box)
- 10 strips of 10 tablets each
- Salt Composition
- Bosutinib Monohydrate
- Origin of Medicine
- Allopathic
- Drug Type
- Pharmaceutical
- Ingredients
- Bosutinib
- Physical Form
- Tablet
- Function
- Used to treat certain types of chronic myeloid leukemia (CML)
- Recommended For
- Adults diagnosed with chronic myeloid leukemia
- Dosage
- 400 mg per tablet
- Dosage Guidelines
- Take as prescribed by a healthcare professional typically once daily with food.
- Suitable For
- Adults
- Quantity
- 1 strip containing 10 tablets
- Storage Instructions
- Store in a cool dry place away from light and moisture.
About Bosutris 400 mg Tablet
Bosutris 400 mg Tablet is a pharmaceutical medication containing Bosutinib as the active ingredient in the form of tablets. It is specifically designed to treat certain types of chronic myeloid leukemia (CML) in adults. Each tablet has a dosage of 400 mg and should be taken as prescribed by a healthcare professional, typically once daily with food. The salt composition includes Bosutinib Monohydrate, suitable for adult patients. Each box contains 1 strip with 10 tablets, totaling 10 strips per box. It is an allopathic medicine that should be stored in a cool, dry place away from light and moisture.
FAQs of Bosutris 400 mg Tablet:
Q: What is the recommended dosage for Bosutris 400 mg Tablet?
A: The recommended dosage for Bosutris 400 mg Tablet is 400 mg per tablet to be taken once daily with food as prescribed by a healthcare professional.Q: Who is Bosutris 400 mg Tablet recommended for?
A: Bosutris 400 mg Tablet is recommended for adults diagnosed with chronic myeloid leukemia.Q: What is the salt composition of Bosutris 400 mg Tablet?
A: Bosutris 400 mg Tablet contains Bosutinib Monohydrate as the salt composition.Q: How should Bosutris 400 mg Tablet be stored?
A: Bosutris 400 mg Tablet should be stored in a cool, dry place away from light and moisture.Q: How many tablets are there in each box of Bosutris 400 mg Tablet?
A: Each box of Bosutris 400 mg Tablet contains 10 strips, with each strip containing 10 tablets, totaling to 100 tablets per box.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
More Products in Anti-Cancer Category
Pataxel 100 mg Injection
Origin of Medicine : Synthetic
Ingredients : Paclitaxel 100 mg
Suitable For : Adults
Physical Form : Other, Injection
Drug Type : Other, Anticancer Drug
Pacakaging (Quantity Per Box) : 1 unit per box
Ribomustin 100 mg Injection
Origin of Medicine : Allopathic
Ingredients : Bendamustine Hydrochloride
Suitable For : Adults
Physical Form : Liquid
Drug Type : Injection
Pacakaging (Quantity Per Box) : 1 vial per box
EmciTableten 1 gm Injection
Origin of Medicine : Allopathic
Ingredients : Ceftriaxone Sodium
Suitable For : Adults and children over the prescribed age, Other
Physical Form : Other, Injection
Drug Type : Other, Antibiotic
Pacakaging (Quantity Per Box) : 1 vial per box
Bicatero 50 mg Tablet
Origin of Medicine : Synthetic
Ingredients : Bicalutamide
Suitable For : Adults
Physical Form : Other, Tablet
Drug Type : Other, Pharmaceutical
Pacakaging (Quantity Per Box) : 10 strips per box
Send InquiryOur Products
- Alzheimers
- Anti-Cancer
- Anti-Fungal
- Anti-Viral
- Arthritis
- Blood Disorder
- Bone Disease
- Bone Marrow Disorder
- Bowel Disease
- Critical Care
- Gynaecology
- Liver Disease
- Lung Disease
- Macular Degeneration
- Multiple Sclerosis
- Nausea
- Nephrology
- Organ Transplant
- Orthostatic Hypotension
- Osteoporsis
- Psoriasis
- Skin Disorder
- Vaccines
- Pharmaceutical Injection
- Enoxaparin Sodium Medicine
- Oral Suspension
- Pharmaceutical Tablets
- Allopathic Medicine
229, Metro Mall, Bapa Sitaram Chowk, Opp. RAF Camp, S.P. Ring Road, Vastral, Ahmedabad - 382418, Gujarat, India
Dr. Harsh M Patel
(Director)
Mobile :08071793621
Send Inquiry
Send SMS
Developed and Managed by Infocom Network Private Limited.
